![William Mezzanotte](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Mezzanotte
Hoofd Techniek/Wetenschap/O&O bij CSL LIMITED
Actieve functies van William Mezzanotte
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CSL LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-10-2018 | - |
Human Resources Officer | 01-10-2018 | - | |
University City Science Center
![]() University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Directeur/Bestuurslid | 19-06-2020 | - |
Loopbaan van William Mezzanotte
Eerdere bekende functies van William Mezzanotte
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BELLUS HEALTH | Directeur/Bestuurslid | 24-03-2021 | 01-01-2023 |
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | 01-04-2015 | 01-04-2017 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01-06-2012 | 01-03-2015 |
CSL Behring LLC
![]() CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Hoofd Techniek/Wetenschap/O&O | 01-04-2017 | - |
Corporate Officer/Principal | - | - |
Opleiding van William Mezzanotte
Villanova University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
The Johns Hopkins University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Verenigd Koninkrijk | 2 |
Australië | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 4 |
Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
CSL LIMITED | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
University City Science Center
![]() University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Miscellaneous |
BELLUS Health, Inc.
![]() BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
CSL Behring LLC
![]() CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Beurs
- Insiders
- William Mezzanotte
- Ervaring